Amino Acid Metabolism Disorders Treatment Market – Industry Analysis and forecast (2019 to 2027) – By Type, Component, Application, and Region

Market Scenario

Amino Acid Metabolism Disorders Treatment Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2027, at CAGR of XX% during forecast period of 2019 to 2027. Amino acid is the building block that helps in developing proteins in one’s body. Almost 500 naturally occurring amino acids are known, out of which only 20 are visible in the genetic code. The Amino Acid Metabolism Disorders Treatment Market has witnessed considerable growth in recent years because of advanced research and development on amino acid metabolism disorders treatment. The Amino Acid Metabolism Disorders Treatment Market has become more competitive and price-sensitive owing to the high potential and steady growth of the Amino Acid Metabolism Disorders Treatment Market. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. Amino Acid Metabolism Disorders Treatment Market Drivers and Restrains Several amino acid have applications in the pharmaceuticals industry and helps in providing treatment for numerous chronic diseases. An example, L-DOPA (L-dihydroxyphenylalanine) is used for treating 5-HTP (5-hydroxytryptophan) and Parkinson’s is used for trail treatment for depression. Furthermore, eflornithine drug is also used in treating insomnia or sleeping sickness. Emerging economies are increasingly focusing on research and development on amino acid metabolism syndromes treatment. As this disorder is so common the need for appropriate treatment and early analysis are very vital. Medications is likely to include unhealthy eating habits, supplements, and other drugs. According to, World Health organization (WHO), over XX million people suffer from obesity in 2018. This can be another factor enhancing the growth of this market in near future. Another disease type such lysosomal storage disease is a rare type of disease. As huge number of people are affected by this disease. This is another factor driving growth of this market in coming years. Manufacturers in the Amino Acid Metabolism Disorders Treatment are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers. The global amino acid metabolism disorders treatment market can be divided into product type, sales channel, distributors and Region. Based on sales channel, the global market could be segmented into retail pharmacies, hospital pharmacies, and online sales. Among the all segment, the hospital pharmacies is likely to lead the market over the forecast tenure. In terms of product type, the Amino Acid Metabolism Disorders Treatment Market is segmented into Folic Acid, Vitamin B6&ampB12, Arginine, Thiamine, Vitamin D, Betaine, Sapropterin Dihydrochloride and Carglumic Acid. The carglumic acid segment is expected to lead the market during the forecast period. However, sapropterin dihydrocholoride is projected to witness the extreme growth rate over the course of the forecast period. Based on region, it is studied across Asia Pacific, North America, Europe, Latin America and Middle East Africa. Amino Acid Metabolism Disorders Treatment Market Regional Analysis On the basis of region Amino Acid Metabolism Disorders Treatment market divided into five region such as Asia Pacific, North America, Europe, Latin America, and Middle East Africa. Among all the regions, the North America had the largest market share in 2018 and is projected to lead the market during the forecast period, Because of Countries such as Germany, the U.S., Spain, and France are projected to offer lucrative growth opportunities for players operating in this market. Europe is projected to be the second leading region after North America. Furthermore, increasing nutritional management activities in Asia Pacific is contribution beneficial growth prospects for this market. The objective of the report is to present comprehensive analysis of Amino Acid Metabolism Disorders Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Amino Acid Metabolism Disorders Treatment Market dynamics, structure by analyzing the market segments, and project the Amino Acid Metabolism Disorders Treatment Market size. Clear representation of competitive analysis of key players by Amino Acid Metabolism Disorders Treatment Type, price, financial position, product portfolio, growth strategies, and regional presence in the Amino Acid Metabolism Disorders Treatment Market make the report investor’s guide.

Scope of the Amino Acid Metabolism Disorders Treatment Market

Amino Acid Metabolism Disorders Treatment Market, by Product Type

• Folic Acid • Vitamin B6&ampB12 • Arginine • Thiamine • Vitamin D • Betaine • Sapropterin Dihydrochloride • Carglumic Acid

Amino Acid Metabolism Disorders Treatment Market, by Sales Channel

• Hospital Pharmacies • Retail Pharmacies • Online Stores

Amino Acid Metabolism Disorders Treatment Market, by Region

• Asia Pacific • North America • Europe • Latin America • Middle East Africa

Amino Acid Metabolism Disorders Treatment Market, Major Players

• Recordati S.p.A. • AMINO GmbH • Koninklijke DSM N.V. • Merck KGaA • Kyowa Hakko Kirin Co. • Civentichem • Hoffmann-La Roche Ltd. • Astellas • Biocodex S A • Consumer Healthcare Inc. • Dainippon Sumitomo • ECR Pharmaceuticals • Eisai Co. • Flynn Pharma • Johnson and Johnson • Meda Consumer Healthcare Inc.,

Table of Contents

Amino Acid Metabolism Disorders Treatment Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Amino Acid Metabolism Disorders Treatment Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast 6.1. Global Amino Acid Metabolism Disorders Treatment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, by Product Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Product Type 7.4. Global Amino Acid Metabolism Disorders Treatment Market Size (US$ Bn) Forecast, by Product Type 7.5. Global Amino Acid Metabolism Disorders Treatment Market Analysis, by Product Type 7.6. Global Amino Acid Metabolism Disorders Treatment Market Attractiveness Analysis, by Product Type 8. Global Amino Acid Metabolism Disorders Treatment Market Analysis and Forecast, by Sales Channel 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Sales Channel 8.4. Global Amino Acid Metabolism Disorders Treatment Market Size (US$ Bn) Forecast, by Sales Channel 8.5. Global Amino Acid Metabolism Disorders Treatment Market Analysis, by Sales Channel 8.6. Global Amino Acid Metabolism Disorders Treatment Market Attractiveness Analysis, by Sales Channel 9. Global Amino Acid Metabolism Disorders Treatment Market Analysis, by Region 9.1. Global Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Region 9.2. Global Amino Acid Metabolism Disorders Treatment Market Size (US$ Bn) Forecast, by Region 9.3. Global Amino Acid Metabolism Disorders Treatment Market Attractiveness Analysis, by Region 10. North America Amino Acid Metabolism Disorders Treatment Market Analysis 10.1. Key Findings 10.2. North America Amino Acid Metabolism Disorders Treatment Market Overview 10.3. North America Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Product Type 10.4. North America Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 10.4.1. Folic Acid 10.4.2. Vitamin B6&ampB12 10.4.3. Arginine 10.4.4. Thiamine 10.4.5. Vitamin D 10.4.6. Betaine 10.4.7. Sapropterin Dihydrochloride 10.4.8. Carglumic Acid 10.5. North America Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Sales Channel 10.6. North America Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 10.6.1. Hospital Pharmacies 10.6.2. Retail Pharmacies 10.6.3. Online Stores 10.6.4. Others 10.7. North America Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Country 10.8. North America Amino Acid Metabolism Disorders Treatment Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Amino Acid Metabolism Disorders Treatment Market Analysis, by Country 10.10. U.S. Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 10.10.1. Folic Acid 10.10.2. Vitamin B6&ampB12 10.10.3. Arginine 10.10.4. Thiamine 10.10.5. Vitamin D 10.10.6. Betaine 10.10.7. Sapropterin Dihydrochloride 10.10.8. Carglumic Acid 10.11. U.S. Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 10.11.1. Hospital Pharmacies 10.11.2. Retail Pharmacies 10.11.3. Online Stores 10.11.4. Others 10.12. Canada Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 10.12.1. Folic Acid 10.12.2. Vitamin B6&ampB12 10.12.3. Arginine 10.12.4. Thiamine 10.12.5. Vitamin D 10.12.6. Betaine 10.12.7. Sapropterin Dihydrochloride 10.12.8. Carglumic Acid 10.13. Canada Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 10.13.1. Hospital Pharmacies 10.13.2. Retail Pharmacies 10.13.3. Online Stores 10.13.4. Others 10.14. North America Amino Acid Metabolism Disorders Treatment Market Attractiveness Analysis 10.14.1. By Product Type 10.14.2. By Sales Channel 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Amino Acid Metabolism Disorders Treatment Market Analysis 11.1. Key Findings 11.2. Europe Amino Acid Metabolism Disorders Treatment Market Overview 11.3. Europe Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Product Type 11.4. Europe Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 11.4.1. Folic Acid 11.4.2. Vitamin B6&ampB12 11.4.3. Arginine 11.4.4. Thiamine 11.4.5. Vitamin D 11.4.6. Betaine 11.4.7. Sapropterin Dihydrochloride 11.4.8. Carglumic Acid 11.5. Europe Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Sales Channel 11.6. Europe Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 11.6.1. Hospital Pharmacies 11.6.2. Retail Pharmacies 11.6.3. Online Stores 11.6.4. Others 11.7. Europe Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Country 11.8. Europe Amino Acid Metabolism Disorders Treatment Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Amino Acid Metabolism Disorders Treatment Market Analysis, by Country 11.10. Germany Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 11.10.1. Folic Acid 11.10.2. Vitamin B6&ampB12 11.10.3. Arginine 11.10.4. Thiamine 11.10.5. Vitamin D 11.10.6. Betaine 11.10.7. Sapropterin Dihydrochloride 11.10.8. Carglumic Acid 11.11. Germany Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 11.11.1. Hospital Pharmacies 11.11.2. Retail Pharmacies 11.11.3. Online Stores 11.11.4. Others 11.12. U.K. Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 11.12.1. Folic Acid 11.12.2. Vitamin B6&ampB12 11.12.3. Arginine 11.12.4. Thiamine 11.12.5. Vitamin D 11.12.6. Betaine 11.12.7. Sapropterin Dihydrochloride 11.12.8. Carglumic Acid 11.13. U.K. Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 11.13.1. Hospital Pharmacies 11.13.2. Retail Pharmacies 11.13.3. Online Stores 11.13.4. Others 11.14. France Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 11.14.1. Folic Acid 11.14.2. Vitamin B6&ampB12 11.14.3. Arginine 11.14.4. Thiamine 11.14.5. Vitamin D 11.14.6. Betaine 11.14.7. Sapropterin Dihydrochloride 11.14.8. Carglumic Acid 11.15. France Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 11.15.1. Hospital Pharmacies 11.15.2. Retail Pharmacies 11.15.3. Online Stores 11.15.4. Others 11.16. Italy Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 11.16.1. Folic Acid 11.16.2. Vitamin B6&ampB12 11.16.3. Arginine 11.16.4. Thiamine 11.16.5. Vitamin D 11.16.6. Betaine 11.16.7. Sapropterin Dihydrochloride 11.16.8. Carglumic Acid 11.17. Italy Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 11.17.1. Hospital Pharmacies 11.17.2. Retail Pharmacies 11.17.3. Online Stores 11.17.4. Others 11.18. Spain Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 11.18.1. Folic Acid 11.18.2. Vitamin B6&ampB12 11.18.3. Arginine 11.18.4. Thiamine 11.18.5. Vitamin D 11.18.6. Betaine 11.18.7. Sapropterin Dihydrochloride 11.18.8. Carglumic Acid 11.19. Spain Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 11.19.1. Hospital Pharmacies 11.19.2. Retail Pharmacies 11.19.3. Online Stores 11.19.4. Others 11.20. Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 11.20.1. Folic Acid 11.20.2. Vitamin B6&ampB12 11.20.3. Arginine 11.20.4. Thiamine 11.20.5. Vitamin D 11.20.6. Betaine 11.20.7. Sapropterin Dihydrochloride 11.20.8. Carglumic Acid 11.21. Rest of Europe Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 11.21.1. Hospital Pharmacies 11.21.2. Retail Pharmacies 11.21.3. Online Stores 11.21.4. Others 11.22. Europe Amino Acid Metabolism Disorders Treatment Market Attractiveness Analysis 11.22.1. By Product Type 11.22.2. By Sales Channel 11.23. PEST Analysis 11.24. Key Trend 11.25. Key Development 12. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Analysis 12.1. Key Findings 12.2. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Overview 12.3. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Product Type 12.4. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 12.4.1. Folic Acid 12.4.2. Vitamin B6&ampB12 12.4.3. Arginine 12.4.4. Thiamine 12.4.5. Vitamin D 12.4.6. Betaine 12.4.7. Sapropterin Dihydrochloride 12.4.8. Carglumic Acid 12.5. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Sales Channel 12.6. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 12.6.1. Hospital Pharmacies 12.6.2. Retail Pharmacies 12.6.3. Online Stores 12.6.4. Others 12.7. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Country 12.8. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Analysis, by Country 12.10. China Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 12.10.1. Folic Acid 12.10.2. Vitamin B6&ampB12 12.10.3. Arginine 12.10.4. Thiamine 12.10.5. Vitamin D 12.10.6. Betaine 12.10.7. Sapropterin Dihydrochloride 12.10.8. Carglumic Acid 12.11. China Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 12.11.1. Hospital Pharmacies 12.11.2. Retail Pharmacies 12.11.3. Online Stores 12.11.4. Others 12.12. India Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 12.12.1. Folic Acid 12.12.2. Vitamin B6&ampB12 12.12.3. Arginine 12.12.4. Thiamine 12.12.5. Vitamin D 12.12.6. Betaine 12.12.7. Sapropterin Dihydrochloride 12.12.8. Carglumic Acid 12.13. India Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 12.13.1. Hospital Pharmacies 12.13.2. Retail Pharmacies 12.13.3. Online Stores 12.13.4. Others 12.14. Japan Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 12.14.1. Folic Acid 12.14.2. Vitamin B6&ampB12 12.14.3. Arginine 12.14.4. Thiamine 12.14.5. Vitamin D 12.14.6. Betaine 12.14.7. Sapropterin Dihydrochloride 12.14.8. Carglumic Acid 12.15. Japan Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 12.15.1. Hospital Pharmacies 12.15.2. Retail Pharmacies 12.15.3. Online Stores 12.15.4. Others 12.16. ASEAN Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 12.16.1. Folic Acid 12.16.2. Vitamin B6&ampB12 12.16.3. Arginine 12.16.4. Thiamine 12.16.5. Vitamin D 12.16.6. Betaine 12.16.7. Sapropterin Dihydrochloride 12.16.8. Carglumic Acid 12.17. ASEAN Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 12.17.1. Hospital Pharmacies 12.17.2. Retail Pharmacies 12.17.3. Online Stores 12.17.4. Others 12.18. Rest of Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 12.18.1. Folic Acid 12.18.2. Vitamin B6&ampB12 12.18.3. Arginine 12.18.4. Thiamine 12.18.5. Vitamin D 12.18.6. Betaine 12.18.7. Sapropterin Dihydrochloride 12.18.8. Carglumic Acid 12.19. Rest of Asia Pacific Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 12.19.1. Unitized 12.19.2. Stick 12.20. Asia Pacific Amino Acid Metabolism Disorders Treatment Market Attractiveness Analysis 12.20.1. By Product Type 12.20.2. By Sales Channel 12.21. PEST Analysis 12.22. Key Trend 12.23. Key Development 13. Middle East & Africa Amino Acid Metabolism Disorders Treatment Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Amino Acid Metabolism Disorders Treatment Market Overview 13.3. Middle East & Africa Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Product Type 13.4. Middle East & Africa Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 13.4.1. Folic Acid 13.4.2. Vitamin B6&ampB12 13.4.3. Arginine 13.4.4. Thiamine 13.4.5. Vitamin D 13.4.6. Betaine 13.4.7. Sapropterin Dihydrochloride 13.4.8. Carglumic Acid 13.5. Middle East & Africa Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Sales Channel 13.6. Middle East & Africa Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 13.6.1. Hospital Pharmacies 13.6.2. Retail Pharmacies 13.6.3. Online Stores 13.6.4. Others 13.7. Middle East & Africa Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Country 13.8. Middle East & Africa Amino Acid Metabolism Disorders Treatment Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Amino Acid Metabolism Disorders Treatment Market Analysis, by Country 13.10. GCC Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 13.10.1. Folic Acid 13.10.2. Vitamin B6&ampB12 13.10.3. Arginine 13.10.4. Thiamine 13.10.5. Vitamin D 13.10.6. Betaine 13.10.7. Sapropterin Dihydrochloride 13.10.8. Carglumic Acid 13.11. GCC Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 13.11.1. Hospital Pharmacies 13.11.2. Retail Pharmacies 13.11.3. Online Stores 13.11.4. Others 13.12. South Africa Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 13.12.1. Folic Acid 13.12.2. Vitamin B6&ampB12 13.12.3. Arginine 13.12.4. Thiamine 13.12.5. Vitamin D 13.12.6. Betaine 13.12.7. Sapropterin Dihydrochloride 13.12.8. Carglumic Acid 13.13. South Africa Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 13.13.1. Hospital Pharmacies 13.13.2. Retail Pharmacies 13.13.3. Online Stores 13.13.4. Others 13.14. Rest of Middle East & Africa Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 13.14.1. Folic Acid 13.14.2. Vitamin B6&ampB12 13.14.3. Arginine 13.14.4. Thiamine 13.14.5. Vitamin D 13.14.6. Betaine 13.14.7. Sapropterin Dihydrochloride 13.14.8. Carglumic Acid 13.15. Rest of Middle East & Africa Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 13.15.1. Hospital Pharmacies 13.15.2. Retail Pharmacies 13.15.3. Online Stores 13.15.4. Others 13.16. Middle East & Africa Amino Acid Metabolism Disorders Treatment Market Attractiveness Analysis 13.16.1. By Product Type 13.16.2. By Sales Channel 13.17. PEST Analysis 13.18. Key Trend 13.19. Key Development 14. South America Amino Acid Metabolism Disorders Treatment Market Analysis 14.1. Key Findings 14.2. South America Amino Acid Metabolism Disorders Treatment Market Overview 14.3. South America Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Product Type 14.4. South America Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 14.4.1. Folic Acid 14.4.2. Vitamin B6&ampB12 14.4.3. Arginine 14.4.4. Thiamine 14.4.5. Vitamin D 14.4.6. Betaine 14.4.7. Sapropterin Dihydrochloride 14.4.8. Carglumic Acid 14.5. Others South America Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Sales Channel 14.6. South America Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 14.6.1. Hospital Pharmacies 14.6.2. Retail Pharmacies 14.6.3. Online Stores 14.6.4. Others 14.7. South America Amino Acid Metabolism Disorders Treatment Market Value Share Analysis, by Country 14.8. South America Amino Acid Metabolism Disorders Treatment Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. Brazil Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 14.9.1. Folic Acid 14.9.2. Vitamin B6&ampB12 14.9.3. Arginine 14.9.4. Thiamine 14.9.5. Vitamin D 14.9.6. Betaine 14.9.7. Sapropterin Dihydrochloride 14.9.8. Carglumic Acid 14.10. Brazil Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 14.10.1. Hospital Pharmacies 14.10.2. Retail Pharmacies 14.10.3. Online Stores 14.10.4. Others 14.11. Mexico Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 14.11.1. Folic Acid 14.11.2. Vitamin B6&ampB12 14.11.3. Arginine 14.11.4. Thiamine 14.11.5. Vitamin D 14.11.6. Betaine 14.11.7. Sapropterin Dihydrochloride 14.11.8. Carglumic Acid 14.12. Mexico Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 14.12.1. Hospital Pharmacies 14.12.2. Retail Pharmacies 14.12.3. Online Stores 14.12.4. Others 14.13. Rest of South America Amino Acid Metabolism Disorders Treatment Market Forecast, by Product Type 14.13.1. Folic Acid 14.13.2. Vitamin B6&ampB12 14.13.3. Arginine 14.13.4. Thiamine 14.13.5. Vitamin D 14.13.6. Betaine 14.13.7. Sapropterin Dihydrochloride 14.13.8. Carglumic Acid 14.14. Rest of South America Amino Acid Metabolism Disorders Treatment Market Forecast, by Sales Channel 14.14.1. Hospital Pharmacies 14.14.2. Retail Pharmacies 14.14.3. Online Stores 14.14.4. Others 14.15. South America Amino Acid Metabolism Disorders Treatment Market Attractiveness Analysis 14.15.1. By Product Type 14.15.2. By Sales Channel 14.16. PEST Analysis 14.17. Key Trend 14.18. Key Development 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Koninklijke DSM N.V. 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Company Footprint 15.3.2. Recordati S.p.A. 15.3.3. AMINO GmbH 15.3.4. Merck KGaA 15.3.5. Kyowa Hakko Kirin Co. 15.3.6. Civentichem 15.3.7. Hoffmann-La Roche Ltd. 15.3.8. Astellas 15.3.9. Biocodex S A 15.3.10. Consumer Healthcare Inc. 15.3.11. Dainippon Sumitomo 15.3.12. ECR Pharmaceuticals 15.3.13. Eisai Co. 15.3.14. Flynn Pharma 15.3.15. Johnson and Johnson 15.3.16. Meda Consumer Healthcare Inc., 16. Primary Key Insights

About This Report

Report ID 39775
Category Healthcare
Published Date Dec 2019
No of Pages 183
Contact Us